Dr. Elizabeth Hong-Geller has nearly 25 years of experience in the bioscience and biodefense communities. During her tenure at LANL, she has led many research projects that focus on host-pathogen interactions—including RNA interference, the design of chimeric proteins to inhibit Staphylococcus aureus superantigens, host immune responses to beryllium exposure, and Toll-like receptor 4 function in innate immunity. Elizabeth has directed Select Agent work and has served as a Biology subject matter expert for several projects including some that crosscut classified work. She also played a leadership role as the LANL point-of-contact for the Next-Generation Lab-Testing Working Group for the National Virtual Biotechnology Laboratory (NVBL), a consortium of national labs focused on COVID-19 Research and Development,. Elizabeth is a recipient of a LANL Individual Distinguished Performance Award in 2020 and has been invited to support the National Academies’ Biotechnology and National Security Committee.
